Norman Chen
Industry Q&A: Norman Chen, Partner, Fidelity Asia Ventures
Chen talks to AVCJ’s Paul Mackintosh about opportunities for healthcare investments in China
Healthcare: The next China VC horizon?
Although it doesn't always register prominently on the radar, healthcare and related biotech actually accounts for 30% or more of all venture capital investment in the US.

